Gilgamesh Pharmaceuticals (Series A)

Funding Details
Awarder
Inbox
Date Award
May 06, 2021
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$27,000,000

Company Info
Founders
Dr. Jonathan Sporn
Company Description
Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.
Market
Mental Health
Location
New York, New York, USA
Coinvestors
Gron Ventures, JLS Fund, Noetic Psychedelic Fund, Palo Santo Investors, Prime Movers Lab, Route 66 Ventures

Links